GIFLF:OTCMKTS
Grifols SA Class A
11,13 USD
0,00%
(0,00) 1D
15 wrz, 15:11:14 GMT-4 · USD
search
Wszystkie symbole
| Symbol | Cena | Zmiana | Zmiana % |
|---|
insights_autoGeneruję najważniejsze statystyki dotyczące: GIFLF…
Kapitalizacja
6,69 mld
Śr. wol.
543,00
Wolumen
0,00
Najwyższa z 52 tyg.
12,90 USD
Minimum z 52 tyg.
10,13 USD
Beta
0,90
Akcje w obiegu
426,13 mln
Liczba pracowników
25 tys.
Kapitalizacja
6,69 mld
Śr. wol.
543,00
Wolumen
0,00
Najwyższa z 52 tyg.
12,90 USD
Minimum z 52 tyg.
10,13 USD
Beta
0,90
Akcje w obiegu
426,13 mln
Liczba pracowników
25 tys.
Wiadomości
Ze źródeł internetowych i od partnerskich agencji informacyjnych
AD HOC NEWS
·
20 godzin temu
Grifols stock was upgraded as first-half profit rose
AD HOC NEWS
·
1 dzień temu
Grifols stock pre-market: EUR 9.84, prior close EUR 9.87
AD HOC NEWS
·
1 dzień temu
Grifols stock reports stronger first half with profit up 28.7%
AD HOC NEWS
·
1 dzień temu
Grifols stock costs EUR 9.93 ahead of November results
Profil
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30.
Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
Grifols SA Class A – informacje